The earliest contact between antigen and the innate immune system is thought to direct the subsequent antigen-specific T cell response. We hypothesized that cells of the innate immune system, such as natural killer (NK) cells, NK1.1+ T cells (NKT cells), and γ/δ T cells, may regulate the development of allergic airway disease. We demonstrate here that depletion of NK1.1+ cells (NK cells and NKT cells) before immunization inhibits pulmonary eosinophil and CD3+ T cell infiltration as well as increased levels of interleukin (IL)-4, IL-5, and IL-12 in bronchoalveolar lavage fluid in a murine model of allergic asthma. Moreover, systemic allergen-specific immunoglobulin (Ig)E and IgG2a levels and the number of IL-4 and interferon γ–producing splenic cells were diminished in mice depleted of NK1.1+ cells before the priming regime. Depletion of NK1.1+ cells during the challenge period only did not influence pulmonary eosinophilic inflammation. CD1d1 mutant mice, deficient in NKT cells but with normal NK cells, developed lung tissue eosinophilia and allergen-specific IgE levels not different from those observed in wild-type mice. Mice deficient in γ/δ T cells showed a mild attenuation of lung tissue eosinophilia in this model. Taken together, these findings suggest a critical role of NK cells, but not of NKT cells, for the development of allergen-induced airway inflammation, and that this effect of NK cells is exerted during the immunization. If translatable to humans, these data suggest that NK cells may be critically important for deciding whether allergic eosinophilic airway disease will develop. These observations are also compatible with a pathogenic role for the increased NK cell activity observed in human asthma.
Skip Nav Destination
Article navigation
1 February 1999
Article|
February 01 1999
Natural Killer Cells Determine Development of Allergen-induced Eosinophilic Airway Inflammation in Mice
Magnus Korsgren,
Magnus Korsgren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Carl G.A. Persson,
Carl G.A. Persson
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Frank Sundler,
Frank Sundler
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Torbjörn Bjerke,
Torbjörn Bjerke
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Tony Hansson,
Tony Hansson
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Benedict J. Chambers,
Benedict J. Chambers
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Seokmann Hong,
Seokmann Hong
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Luc Van Kaer,
Luc Van Kaer
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Hans-Gustaf Ljunggren,
Hans-Gustaf Ljunggren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Olle Korsgren
Olle Korsgren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Search for other works by this author on:
Magnus Korsgren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Carl G.A. Persson
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Frank Sundler
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Torbjörn Bjerke
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Tony Hansson
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Benedict J. Chambers
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Seokmann Hong
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Luc Van Kaer
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Hans-Gustaf Ljunggren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Olle Korsgren
From the *Department of Physiology and Neuroscience, and ‡Department of Clinical Pharmacology, Lund University Hospital, 221 85 Lund, Sweden; §Department of Inflammation Pharmacology, Astra Draco, 221 00 Lund, Sweden; ‖Microbiology and Tumor Biology Center, Karolinska Institute, 171 77 Stockholm, Sweden; ¶Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and **Department of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, 751 85 Uppsala, Sweden
Address correspondence to Magnus Korsgren, Department of Physiology and Neuroscience, Neuroendocrine Cell Biology, E-blocket, University Hospital, 221 85 Lund, Sweden. Phone: 46-46-177714; Fax: 46-46-177720; E-mail: [email protected]
Received:
September 02 1998
Revision Received:
October 13 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (3): 553–562.
Article history
Received:
September 02 1998
Revision Received:
October 13 1998
Citation
Magnus Korsgren, Carl G.A. Persson, Frank Sundler, Torbjörn Bjerke, Tony Hansson, Benedict J. Chambers, Seokmann Hong, Luc Van Kaer, Hans-Gustaf Ljunggren, Olle Korsgren; Natural Killer Cells Determine Development of Allergen-induced Eosinophilic Airway Inflammation in Mice . J Exp Med 1 February 1999; 189 (3): 553–562. doi: https://doi.org/10.1084/jem.189.3.553
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement